JP2021514973A5 - - Google Patents
Info
- Publication number
- JP2021514973A5 JP2021514973A5 JP2020544813A JP2020544813A JP2021514973A5 JP 2021514973 A5 JP2021514973 A5 JP 2021514973A5 JP 2020544813 A JP2020544813 A JP 2020544813A JP 2020544813 A JP2020544813 A JP 2020544813A JP 2021514973 A5 JP2021514973 A5 JP 2021514973A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cdr
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023218543A JP7705442B2 (ja) | 2018-02-26 | 2023-12-25 | Ａｎｔｉ－ｍｕｃｉ＊抗体を用いた診断法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635378P | 2018-02-26 | 2018-02-26 | |
| US62/635,378 | 2018-02-26 | ||
| US201862640697P | 2018-03-09 | 2018-03-09 | |
| US62/640,697 | 2018-03-09 | ||
| PCT/US2018/062569 WO2019104306A1 (en) | 2017-11-27 | 2018-11-27 | Humanized anti-muc1* antibodies and direct use of cleavage enzyme |
| USPCT/US18/62569 | 2018-11-27 | ||
| US201962791661P | 2019-01-11 | 2019-01-11 | |
| US62/791,661 | 2019-01-11 | ||
| PCT/US2019/019566 WO2019165421A1 (en) | 2018-02-26 | 2019-02-26 | Diagnostic methods using anti-muc1* antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023218543A Division JP7705442B2 (ja) | 2018-02-26 | 2023-12-25 | Ａｎｔｉ－ｍｕｃｉ＊抗体を用いた診断法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021514973A JP2021514973A (ja) | 2021-06-17 |
| JP2021514973A5 true JP2021514973A5 (enExample) | 2022-03-07 |
| JP7411559B2 JP7411559B2 (ja) | 2024-01-11 |
Family
ID=67688578
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544813A Active JP7411559B2 (ja) | 2018-02-26 | 2019-02-26 | Ａｎｔｉ－ｍｕｃｉ＊抗体を用いた診断法 |
| JP2023218543A Active JP7705442B2 (ja) | 2018-02-26 | 2023-12-25 | Ａｎｔｉ－ｍｕｃｉ＊抗体を用いた診断法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023218543A Active JP7705442B2 (ja) | 2018-02-26 | 2023-12-25 | Ａｎｔｉ－ｍｕｃｉ＊抗体を用いた診断法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11976132B2 (enExample) |
| EP (1) | EP3759145A4 (enExample) |
| JP (2) | JP7411559B2 (enExample) |
| CN (1) | CN112272677B (enExample) |
| AU (2) | AU2019225237B2 (enExample) |
| CA (1) | CA3092247A1 (enExample) |
| IL (1) | IL276925A (enExample) |
| WO (1) | WO2019165421A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2019165421A1 (en) | 2018-02-26 | 2019-08-29 | Minerva Biotechnologies Corporation | Diagnostic methods using anti-muc1* antibodies |
| WO2020146902A2 (en) * | 2019-01-11 | 2020-07-16 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| CN119930824A (zh) * | 2020-01-13 | 2025-05-06 | 真和制药有限公司 | 抗Gal3抗体和使用方法 |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| WO2021257894A1 (en) * | 2020-06-19 | 2021-12-23 | Board Of Regents, The University Of Texas System | Anti-bst2 antibodies targeting bst2 long isoform |
| CA3183682A1 (en) | 2020-06-26 | 2021-12-30 | Minerva Biotechnologies Corporation | Anti-nme antibody and method of treating cancer or cancer metastasis |
| GR20200100703A (el) * | 2020-11-26 | 2022-06-08 | Icarus Antibodies Ι.Κ.Ε, | Μονοκλωνικα αντισωματα εναντι του κορωνοϊου sars-cov-2 και χρησεις αυτων |
| CN116554317B (zh) * | 2022-01-29 | 2025-02-28 | 浙江纳米抗体技术中心有限公司 | Muc1结合分子及其应用 |
| US20230296605A1 (en) | 2022-03-18 | 2023-09-21 | Novascope Biochips Inc. | Antibody for porcine reproductive and respiratory syndrome virus and uses thereof |
| CN116925216B (zh) * | 2022-04-11 | 2024-09-24 | 东莞市朋志生物科技有限公司 | 抗血清淀粉样蛋白a抗体、检测血清淀粉样蛋白a的试剂和试剂盒 |
| CA3248038A1 (en) | 2022-04-12 | 2023-10-19 | Minerva Biotechnologies Corporation | ANTI-MUC1* VARIABLE ANTIBODIES AND RELATED USES |
| US20240261406A1 (en) | 2023-02-02 | 2024-08-08 | Minerva Biotechnologies Corporation | Chimeric antigen receptor compositions and methods for treating muc1* diseases |
| IL326916A (en) | 2023-08-29 | 2026-05-01 | Minerva Biotechnologies Corp | Bacterial orthologs of NME7 and their uses |
| CN117820483B (zh) * | 2024-03-01 | 2024-05-28 | 北京纳百生物科技有限公司 | 一种猫n-端脑利钠肽前体蛋白单克隆抗体、检测试纸条及应用 |
| WO2025255276A1 (en) * | 2024-06-04 | 2025-12-11 | Fred Hutchinson Cancer Center | Anti-whitlow linker binding domains and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002022685A2 (en) | 2000-09-11 | 2002-03-21 | Kufe Donald W | Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| KR20090088896A (ko) | 2006-11-09 | 2009-08-20 | 아이알엠 엘엘씨 | 효현제 ｔｒｋｂ 항체 및 그의 용도 |
| RU2014123030A (ru) | 2011-12-22 | 2016-02-20 | Ринат Ньюросайенс Корп. | Антагонистические антитела против человеческого рецептора гормона роста и способы их применения |
| JP6476170B2 (ja) | 2014-04-28 | 2019-03-06 | 医化学創薬株式会社 | 抗ｍｕｃ１抗体又はその抗原結合性断片及びその用途 |
| EP3256494A4 (en) * | 2015-02-10 | 2018-12-05 | Minerva Biotechnologies Corporation | Humanized anti-muc1* antibodies |
| WO2019165421A1 (en) | 2018-02-26 | 2019-08-29 | Minerva Biotechnologies Corporation | Diagnostic methods using anti-muc1* antibodies |
| WO2020146902A2 (en) * | 2019-01-11 | 2020-07-16 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
-
2019
- 2019-02-26 WO PCT/US2019/019566 patent/WO2019165421A1/en not_active Ceased
- 2019-02-26 CA CA3092247A patent/CA3092247A1/en active Pending
- 2019-02-26 AU AU2019225237A patent/AU2019225237B2/en active Active
- 2019-02-26 EP EP19757027.8A patent/EP3759145A4/en active Pending
- 2019-02-26 CN CN201980027373.9A patent/CN112272677B/zh active Active
- 2019-02-26 JP JP2020544813A patent/JP7411559B2/ja active Active
- 2019-02-26 US US16/975,625 patent/US11976132B2/en active Active
-
2020
- 2020-08-25 IL IL276925A patent/IL276925A/en unknown
-
2023
- 2023-12-25 JP JP2023218543A patent/JP7705442B2/ja active Active
-
2024
- 2024-03-21 US US18/612,767 patent/US12351646B2/en active Active
- 2024-11-01 US US18/935,308 patent/US20250066505A1/en active Pending
-
2026
- 2026-03-16 AU AU2026201952A patent/AU2026201952A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7254699B2 (ja) | 抗ｂｃｍａ重鎖のみ抗体 | |
| RU2008149918A (ru) | Антитела к nkg2a и их применения | |
| JP7257971B6 (ja) | 抗ｃｄ４０抗体、その抗原結合フラグメント、およびその医学的使用 | |
| NZ585559A (en) | Humanized antibodies against tl1a | |
| RU2017137010A (ru) | Анти-сеасам6 антитела и их применения | |
| JP2018183173A5 (enExample) | ||
| JP2014511179A5 (enExample) | ||
| JP2018510636A5 (enExample) | ||
| JP2021501162A5 (enExample) | ||
| JP2017052784A5 (enExample) | ||
| JP2017535257A5 (enExample) | ||
| JP2017534577A5 (enExample) | ||
| RU2012119788A (ru) | Связывающие il-1 белки | |
| JP2016512551A5 (enExample) | ||
| JP2020513791A5 (enExample) | ||
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2016510002A5 (enExample) | ||
| RU2017126476A (ru) | Новые модуляторы и способы их применения | |
| JP2011506483A5 (enExample) | ||
| US20110117079A1 (en) | Therapeutic dll4 binding proteins | |
| JP2016538318A5 (enExample) | ||
| JP2022533538A5 (enExample) | ||
| JP2016505546A5 (enExample) | ||
| JP2016527225A5 (enExample) | ||
| JP2022514734A5 (enExample) |